Clinical Trial Update: Avonex PEN Satisfaction and Patients Experience Clinical Trial

View source ↗

Summary

A completed study evaluating satisfaction and patient experience with Avonex PEN in people with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex PEN (interferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: COMPLETED